Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
25 Cards in this Set
- Front
- Back
Other names for Dextrose 50% 02
|
D50
|
|
Dextrose Mechanism of Action
|
Increases circulating blood sugar levels to normal.
It also acts briefly as an osmotic diuretic |
|
Dextrose Therapeutic Benefit
|
Restores circulating blood sugar levels to normal
|
|
Dextrose Pharmacologic Class
|
Carbohydrate
|
|
Dextrose Therapeutic Class
|
Hyperglycemic
|
|
Dextrose Contraindications
|
Hypersensitivity to the drug.
Intracranial hemorrhage. |
|
Dextrose Indications for use
|
Pts in coma due to hypoglycemia and unknown cause.
Pts with altered level of consciousness with low reagent strip reading <60mg/dl. Cardiac arrest situations. |
|
Dextrose Precautions
|
Use cautiously in patients with diabetes mellitus who can not tolerate carbohydrate agents.
|
|
Dextrose Route and Dosage
|
Adult:
12.5-25 grams by slow IV bolus Pediatric: Dilute 1:1 with sterile water to make a 25% solution (D25W) (0.25mg/ml) 0.5-1.0 g/kg by slow IV bolus |
|
Dextrose Side Effects
|
CNS: fever, confusion, unconscious in HHS
CV: worsened hypertension and CHF. RESP: Pulmonary edema GU: osmotic diuresis. |
|
Dextrose Drug Interactions
|
Corticosteriods may cause salt and water retention and increase potassium losses.
|
|
Dextrose ALS Protocols
|
PA-ALS Protocol 7002
|
|
Glucagon Pharmacologic Class
|
Antihypoglycemic
|
|
Glucagon Therapeutic Class
|
Antihypoglycemic
|
|
Glucagon Mechanism of Action
|
Glucagon is a hormone excreted by the alpha cells of the pancreas. When released, glucagon increases the level of circulating blood sugar by stimulating the release of glycogen from the liver. The glycogen is quickly broken down to become glucose.
|
|
Glugagon Therapeutic Benefit
|
Glucagon causes an increase in the plasma glucose levels of the circulating blood, causes smooth muscle relaxation, and has positive inotropic and chronotropic effects on the heart.
|
|
Glucagon Indications for use
|
Treat hypoglycemia in the unconscious, combative patient and in situations where an IV line cannot be established.
Gastric relaxation |
|
Glucagon Contraindications
|
Hypersensitivity
|
|
Glucagon Precautions
|
Use caution in administering to patients with pheochromocytoma. *Pheochromocytoma is a catecholamine-secreting tumor that may cause hypertension. Since glucagons stimulates the release of catecholamines the blood pressure will increase.
|
|
Glucagon Route and Dosage
|
Adult: 1mg IM. *For gastric relaxation 1mg is given IV.
Pediatric: 1mg IM if ≥20kg or ≥5yo. 0.5mg if <20kg or <5 yo. Can be repeated in 15 minutes if necessary. |
|
Glucagon Side Effects
|
CNS: Dizziness
CV: Possible hypotension GI: Nausea & vomiting RESP: Bronchospasm, respiratory distress |
|
Glucagon Drug Interactions
|
A precipitate will form if glucagons is mixed with chloride solutions.
|
|
Glucagon ALS Protocols
|
PA ALS 7002A 1-4
7002P 1-4 |
|
Glucagon Onset, Peak and Duration
|
Onset:
4-10 min IM, 1 min IV Peak: Unknown IM, 30 min IV Duration: 12-32 min IM, 9-25 min IV |
|
Glucagon Special Note
|
Glucagon comes in vials that contain 1mg (1 unit vial of powder) and 2 ml of diluting solution (use solution as supplied by the manufacturer or sterile water for injection may be substituted. Glucagon must be reconstituted (mixed) before use.
|